Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

NNNN

Anbio Biotechnology

Jan 16 • 04:00PM ET

32.53

-2.06 -5.96 %

Healthcare • Medical Instruments & Supplies • Germany • NASD

Index	-	P/E	514.72	EPS (ttm)	0.06	Insider Own	9.57%	Shs Outstand	43.89M	Perf Week	-7.03%
Market Cap	4.68B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	39.69M	Perf Month	16.14%
Enterprise Value	4.67B	PEG	-	EPS next Q	-	Inst Own	0.16%	Short Float	0.12%	Perf Quarter	17.35%
Income	2.82M	P/S	620.79	EPS this Y	-	Inst Trans	1.88%	Short Ratio	1.38	Perf Half Y	-30.77%
Sales	7.54M	P/B	44.15	EPS next Y	-	ROA	10.70%	Short Interest	0.05M	Perf YTD	8.18%
Book/sh	0.74	P/C	297.00	EPS next 5Y	-	ROE	10.84%	52W High	55.65 -41.55%	Perf Year	-
Cash/sh	0.11	P/FCF	2080.35	EPS past 3/5Y	-5.05% -	ROIC	8.73%	52W Low	5.18 527.99%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	2404.65	Sales past 3/5Y	19.15% -	Gross Margin	89.72%	Volatility	15.49% 14.28%	Perf 5Y	-
Dividend TTM	-	EV/Sales	618.70	EPS Y/Y TTM	-42.91%	Oper. Margin	25.78%	ATR (14)	4.68	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	211.10	Sales Y/Y TTM	-26.65%	Profit Margin	37.47%	RSI (14)	49.20	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	211.10	EPS Q/Q	2.83%	SMA20	-3.35%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-20.80%	SMA50	9.79%	Rel Volume	0.99	Prev Close	34.59
Employees	27	LT Debt/Eq	0.00	Earnings	-	SMA200	16.25%	Avg Volume	34.03K	Price	32.53
IPO	Feb 19, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	33,692	Change	-5.96%

Aug-08-25 09:05PM	Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System (GlobeNewswire) +10.88% -7.89%
Jul-09-25 10:31AM	Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN) (Insider Monkey) +14.50%
Jul-04-25 06:00AM	The IPO market in 2025 is being driven by a clear theme bigger is better (Yahoo Finance)
May-15-25 01:05AM	Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions (GlobeNewswire) +6.12%
Feb-20-25 09:50AM	Anbio Biotechnology Announces Closing of Initial Public Offering (GlobeNewswire)
06:10PM	Loading…
Feb-18-25 06:10PM	Anbio Biotechnology Announces Pricing of Initial Public Offering (GlobeNewswire)

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NNNN

Anbio Biotechnology

Upgrade your FINVIZ experience